Elephas Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
120
- Latest Deal Type
-
Series B2
- Latest Deal Amount
-
$42.7M
- Investors
-
9
Elephas General Information
Description
Developer of live tumor diagnostic technology designed to assess patient response to immunotherapy from core needle biopsy samples before treatment initiation. The company offers a platform that integrates cancer biology, multimodal microscopy, engineering, artificial intelligence, and analysis of live human tumor fragments, enabling clinicians to inform treatment decisions for cancer patients and support drug development efforts.
Contact Information
Website
www.elephas.comCorporate Office
- 1 Erdman Place
- Suite 100
- Madison, WI 53717
- United States
Corporate Office
- 1 Erdman Place
- Suite 100
- Madison, WI 53717
- United States
Elephas Timeline
Elephas Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B2) | 06-Nov-2025 | $42.7M | Completed | Clinical Trials - General | ||
| 4. Later Stage VC (Series B1) | 08-Jan-2024 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC (Series B) | 06-Sep-2022 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series A) | 15-Sep-2021 | $21M | $28M | Completed | Clinical Trials - General | |
| 1. Seed Round | 15-May-2021 | $7M | $7M | Completed | Clinical Trials - General |
Elephas Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A | ||||||||
| Seed 2 | 1,019,214 | $0.000010 | $5.89 | $5.89 | 1x | $5.89 | 5.26% | |
| Seed 1 | 1,183,168 | $0.000010 | $0.85 | $0.85 | 1x | $0.85 | 6.11% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Elephas Patents
Elephas Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260202290-A1 | Systems and methods for embedding and cutting tissue sample | Pending | 15-Jan-2025 | ||
| WO-2026156127-A1 | Systems and methods for embedding and cutting tissue sample | Pending | 15-Jan-2025 | ||
| US-12467918-B1 | Systems and methods for measuring changes in cellular activity in live tissue | Active | 10-Jan-2025 | ||
| US-20260202396-A1 | Systems and methods for measuring changes in cellular activity in live tissue | Pending | 10-Jan-2025 | ||
| WO-2026151959-A1 | Systems and methods for measuring changes in cellular activity in live tissue | Pending | 10-Jan-2025 | G01N33/575 |
Elephas Signals
Elephas Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Clarevia Ventures | Venture Capital | Minority | ||
| State of Wisconsin Investment Board | Government | Minority | ||
| ARCH Venture Partners | Venture Capital | Minority | ||
| Moore Capital Management | Hedge Fund | Minority | ||
| Moore Strategic Ventures | Venture Capital | Minority |
Elephas FAQs
-
When was Elephas founded?
Elephas was founded in 2020.
-
Where is Elephas headquartered?
Elephas is headquartered in Madison, WI.
-
What is the size of Elephas?
Elephas has 120 total employees.
-
What industry is Elephas in?
Elephas’s primary industry is Diagnostic Equipment.
-
Is Elephas a private or public company?
Elephas is a Private company.
-
What is the current valuation of Elephas?
The current valuation of Elephas is .
-
What is Elephas’s current revenue?
The current revenue for Elephas is .
-
How much funding has Elephas raised over time?
Elephas has raised $169M.
-
Who are Elephas’s investors?
Clarevia Ventures, State of Wisconsin Investment Board, ARCH Venture Partners, Moore Capital Management, and Moore Strategic Ventures are 5 of 9 investors who have invested in Elephas.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process